Shares of Inovio Pharmaceuticals jumped 6.14% to $9.16 at 20:45 EST on Wednesday, following last session’s downward trend. NASDAQ Composite is rising 1.19% to $13,950.22, after two sequential sessions in a row of losses. This seems, up to now, an all-around positive trend exchanging session today.

Inovio Pharmaceuticals’s last close was $8.63, 268.89% below its 52-week high of $33.79.

Inovio Pharmaceuticals’s Sales

Inovio Pharmaceuticals’s sales growth is a negative 35.9% for the ongoing quarter and 237.1% for the next. The company’s growth estimates for the current quarter and the next is 30.8% and 77.1%, respectively.

Inovio Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth grew by 1896.7%, now sitting on 7.41M for the twelve trailing months.

Inovio Pharmaceuticals’s Stock Yearly Top and Bottom Value

Inovio Pharmaceuticals’s stock is valued at $9.16 at 20:45 EST, way under its 52-week high of $33.79 and way above its 52-week low of $6.88.

Inovio Pharmaceuticals’s Moving Average

Inovio Pharmaceuticals’s value is way below its 50-day moving average of $10.61 and way below its 200-day moving average of $11.28.

More news about Inovio Pharmaceuticals.


Please enter your comment!
Please enter your name here